TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation

Eric Assier1, Viviana Marin-Esteban, Alain Haziot

  • 1INSERM U662, Université Paris 7, Institut Universitaire d'Hématologie, Centre Hayem, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France.

Summary

Toll-like receptor (TLR) 7/8 agonists, like Resiquimod, impair dendritic cell (DC) differentiation and function. This viral mimicry affects adaptive immunity by altering DC responses to subsequent bacterial signals.